A detailed history of Capital Group Private Client Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 476,057 shares of ABBV stock, worth $79.3 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
476,057
Previous 497,339 4.28%
Holding current value
$79.3 Million
Previous $85.3 Million 10.21%
% of portfolio
0.95%
Previous 0.89%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $3.49 Million - $4.24 Million
-21,282 Reduced 4.28%
476,057 $94 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $1.08 Million - $1.26 Million
-6,987 Reduced 1.39%
497,339 $85.3 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $40.6 Million - $46.3 Million
254,309 Added 101.72%
504,326 $91.8 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $8.05 Million - $9.07 Million
58,530 Added 30.57%
250,017 $38.7 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $1.21 Million - $1.4 Million
9,083 Added 4.98%
191,487 $28.5 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $361,222 - $449,517
-2,726 Reduced 1.47%
182,404 $24.6 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $2.62 Million - $3.02 Million
18,148 Added 10.87%
185,130 $29.5 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $331,944 - $398,088
-2,400 Reduced 1.42%
166,982 $27 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $16,373 - $18,779
-122 Reduced 0.07%
169,382 $22.7 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $5.74 Million - $7.3 Million
41,726 Added 32.66%
169,504 $26 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $16.9 Million - $20.9 Million
127,778 New
127,778 $20.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $295B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.